Squarepoint Ops LLC Eli Lilly & CO Transaction History

Squarepoint Ops LLC

$80.7 Billion
Q1 2025

A detailed history of Squarepoint Ops LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Squarepoint Ops LLC holds 35,945 shares of LLY stock, worth $27.4 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

35,945

Previous 209,760 82.86%

Holding current value

$27.4 Million

Previous $162 Million 81.67%

% of portfolio

0.04%

Previous 0.16%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$725.72 - $929.72 $126 Million - $162 Million	-173,815 Reduced 82.86%	35,945 $29.7 Million
Q4 2024 Feb 14, 2025	BUY	$727.2 - $932.06 $81.7 Million - $105 Million	112,390 Added 115.43%	209,760 $162 Million
Q3 2024 Nov 14, 2024	BUY	$772.14 - $960.02 $35 Million - $43.5 Million	45,339 Added 87.14%	97,370 $86.3 Million
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $11.5 Million - $14.4 Million	15,833 Added 43.74%	52,031 $47.1 Million
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $45.4 Million - $60.7 Million	-76,590 Reduced 67.91%	36,198 $28.2 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $9.43 Million - $11.1 Million	17,955 Added 18.93%	112,788 $65.7 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $33.3 Million - $44.5 Million	94,833 New	94,833 $44.5 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $8.73 Million - $10.2 Million	27,165 Added 30.77%	115,448 $42.2 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $9.86 Million - $11.2 Million	33,261 Added 60.45%	88,283 $28.5 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $12.9 Million - $15.1 Million	46,172 Added 521.72%	55,022 $17.8 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $3.22 Million - $4 Million	-13,702 Reduced 60.76%	8,850 $2.53 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $1.59 Million - $1.97 Million	7,065 Added 45.62%	22,552 $6.23 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $14.8 Million - $18.3 Million	-66,923 Reduced 81.21%	15,487 $3.58 Million
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $2.56 Million - $3.32 Million	14,205 Added 20.83%	82,410 $18.9 Million
Q1 2021 May 17, 2021	SELL	$164.32 - $212.72 $3.91 Million - $5.06 Million	-23,796 Reduced 25.86%	68,205 $12.7 Million
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $28.6 Million - $37.8 Million	-218,948 Reduced 70.41%	92,001 $15.5 Million
Q3 2020 Nov 16, 2020	BUY	$146.22 - $169.13 $28 Million - $32.4 Million	191,427 Added 160.16%	310,949 $46 Million
Q2 2020 Aug 14, 2020	SELL	$136.42 - $164.18 $3.98 Million - $4.8 Million	-29,207 Reduced 19.64%	119,522 $19.6 Million
Q3 2019 Nov 14, 2019	BUY	$106.79 - $116.16 $4.05 Million - $4.4 Million	37,889 Added 34.18%	148,729 $16.6 Million
Q2 2019 Aug 14, 2019	BUY	$110.79 - $129.32 $11.9 Million - $13.9 Million	107,709 Added 3440.08%	110,840 $12.3 Million
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $4.29 Million - $5.05 Million	-38,569 Reduced 92.49%	3,131 $406,000
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $14 Million - $15.7 Million	-132,504 Reduced 76.06%	41,700 $4.83 Million
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $15 Million - $18.7 Million	174,204 New	174,204 $18.7 Million
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $6.12 Million - $7.02 Million	-80,800 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $5.02 Million - $5.92 Million	-67,620 Reduced 45.56%	80,800 $6.25 Million
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $12.2 Million - $13 Million	148,420	148,420 $12.5 Million

Others Institutions Holding LLY

# of Institutions

4,394

Shares Held

821M

Call Options Held

10M

Put Options Held

10.8M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $725B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Eli Lilly & CO Transaction History